Susan P Buchbinder

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States
    Susan P Buchbinder
    AIDS Office, San Francisco Department of Public Health, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 39:82-9. 2005
  2. ncbi request reprint Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation
    Susan P Buchbinder
    AIDS Office, San Francisco Department of Public Health, San Francisco, CA 94102 6033, USA
    J Acquir Immune Defic Syndr 36:604-12. 2004
  3. pmc Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States
    Albert Y Liu
    Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 64:87-94. 2013
  4. pmc Age, race/ethnicity, and behavioral risk factors associated with per contact risk of HIV infection among men who have sex with men in the United States
    Hyman M Scott
    Center for AIDS Prevention Studies, University of California, San Francisco, San Francisco, CA Bridge HIV, San Francisco Department of Public Health, San Francisco, CA Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA Department of Medicine, University of California, San Francisco, San Francisco, CA and PaxVax, San Diego, CA
    J Acquir Immune Defic Syndr 65:115-21. 2014
  5. ncbi request reprint CROI 2013: New tools to understand transmission dynamics and prevent HIV infections
    Susan P Buchbinder
    Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA
    Top Antivir Med 21:47-61. 2013
  6. pmc Sexual frequency and planning among at-risk men who have sex with men in the United States: implications for event-based intermittent pre-exposure prophylaxis
    Jonathan E Volk
    Department of Public Health, HIV Research Section, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 61:112-5. 2012
  7. ncbi request reprint HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial
    Susan P Buchbinder
    Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA Department of Medicine, University of California, San Francisco, CA, USA Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA Electronic address
    Lancet Infect Dis 14:468-75. 2014
  8. pmc The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants
    Jonathan E Volk
    Bridge HIV, Department of Public Health, San Francisco, CA, USA
    Int J STD AIDS 25:332-40. 2014
  9. pmc Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco
    Albert Y Liu
    San Francisco Department of Public Health, San Francisco, California, United States of America
    PLoS ONE 6:e23688. 2011
  10. pmc Preexposure chemoprophylaxis for HIV prevention in men who have sex with men
    Robert M Grant
    J David Gladstone Institutes, University of California at San Francisco, 1650 Owens St, San Francisco, CA 94158, USA
    N Engl J Med 363:2587-99. 2010

Detail Information

Publications28

  1. ncbi request reprint Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States
    Susan P Buchbinder
    AIDS Office, San Francisco Department of Public Health, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 39:82-9. 2005
    ..8, PAR = 7%). Having a large number of male sex partners, nitrite inhalant use, and engaging in receptive anal sex explained the majority of infections in this cohort and should be targeted in prevention strategies for MSM...
  2. ncbi request reprint Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation
    Susan P Buchbinder
    AIDS Office, San Francisco Department of Public Health, San Francisco, CA 94102 6033, USA
    J Acquir Immune Defic Syndr 36:604-12. 2004
    ..To compare hypothetical and actual willingness to enroll in a preventive HIV vaccine trial and identify factors affecting enrollment...
  3. pmc Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States
    Albert Y Liu
    Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 64:87-94. 2013
    ..To evaluate for changes in sexual behaviors associated with daily pill use among men who have sex with men (MSM) participating in a preexposure prophylaxis trial...
  4. pmc Age, race/ethnicity, and behavioral risk factors associated with per contact risk of HIV infection among men who have sex with men in the United States
    Hyman M Scott
    Center for AIDS Prevention Studies, University of California, San Francisco, San Francisco, CA Bridge HIV, San Francisco Department of Public Health, San Francisco, CA Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA Department of Medicine, University of California, San Francisco, San Francisco, CA and PaxVax, San Diego, CA
    J Acquir Immune Defic Syndr 65:115-21. 2014
    ..To explore possible explanations for these disparities and known individual risk factors, we analyzed the per contact risk (PCR) of HIV seroconversion in the early highly active antiretroviral therapy era...
  5. ncbi request reprint CROI 2013: New tools to understand transmission dynamics and prevent HIV infections
    Susan P Buchbinder
    Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA
    Top Antivir Med 21:47-61. 2013
    ..Fortunately, new strategies are being developed that could substantially reduce new infections globally, such as methods to increase adherence and the use of long-acting antiretroviral agents...
  6. pmc Sexual frequency and planning among at-risk men who have sex with men in the United States: implications for event-based intermittent pre-exposure prophylaxis
    Jonathan E Volk
    Department of Public Health, HIV Research Section, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 61:112-5. 2012
    ..A substantial proportion of these MSM endorse high-risk sexual activity, and event-based iPrEP may best target this population...
  7. ncbi request reprint HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial
    Susan P Buchbinder
    Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA Department of Medicine, University of California, San Francisco, CA, USA Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA Electronic address
    Lancet Infect Dis 14:468-75. 2014
    ..We aimed to estimate the PAF and NNT of participants in the iPrEx (Pre-Exposure Prophylaxis Initiative) trial...
  8. pmc The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants
    Jonathan E Volk
    Bridge HIV, Department of Public Health, San Francisco, CA, USA
    Int J STD AIDS 25:332-40. 2014
    ..3, CI 0.58-2.83) or loss to follow-up (OR = 0.8, CI 0.51-1.41). Our data support the inclusion of younger participants who are at risk for HIV in future HIV vaccine efficacy trials...
  9. pmc Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco
    Albert Y Liu
    San Francisco Department of Public Health, San Francisco, California, United States of America
    PLoS ONE 6:e23688. 2011
    ..We determined the baseline prevalence of low bone mineral density (BMD) and the effect of TDF on BMD in men who have sex with men (MSM) in a PrEP trial in San Francisco...
  10. pmc Preexposure chemoprophylaxis for HIV prevention in men who have sex with men
    Robert M Grant
    J David Gladstone Institutes, University of California at San Francisco, 1650 Owens St, San Francisco, CA 94158, USA
    N Engl J Med 363:2587-99. 2010
    ..Antiretroviral chemoprophylaxis before exposure is a promising approach for the prevention of human immunodeficiency virus (HIV) acquisition...
  11. pmc Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP)
    Albert Y Liu
    Bridge HIV, San Francisco Department of Public Health, San Francisco, California, United States of America Department of Medicine, University of California San Francisco UCSF, San Francisco, California, United States of America
    PLoS ONE 9:e83736. 2014
    ..To evaluate the relationship between dose and tenofovir concentrations in hair, we examined the dose proportionality of tenofovir in hair in healthy, HIV-uninfected adults...
  12. ncbi request reprint Antiretroviral use for prevention and other factors affecting the course of the HIV-1 epidemic
    Susan P Buchbinder
    HIV Research Section, San Francisco Department of Public Health, University of California San Francisco, USA
    Top Antivir Med 20:32-40. 2012
    ..Similarly, the potential benefits and harms of serosorting were explored. Investigators explored scale-up of prevention strategies to have the biggest and most cost-effective impact on the global epidemic...
  13. ncbi request reprint Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men
    Albert Y Liu
    Department of Medicine, San Francisco Department of Public Health, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 47:241-7. 2008
    ..Media reports have suggested substantial levels of community PrEP use despite its unproven effectiveness...
  14. pmc Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
    Susan P Buchbinder
    HIV Research Section, San Francisco Department of Public Health, San Francisco, CA, USA
    Lancet 372:1881-93. 2008
    ..The Step Study directly assessed the efficacy of a cell-mediated immunity vaccine to protect against HIV-1 infection or change in early plasma HIV-1 levels...
  15. ncbi request reprint Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion
    Grant N Colfax
    HIV Research Branch, San Francisco Department of Public Health, San Francisco, CA 94102 6033, USA
    AIDS 16:1529-35. 2002
    ..To determine the potential for secondary HIV transmission among newly HIV-infected men who have sex with men (MSM) during their HIV antibody seroconversion period, and for the 12 months after seroconversion...
  16. pmc Lessons drawn from recent HIV vaccine efficacy trials
    Jonathan D Fuchs
    HIV Research Section, San Francisco Department of Public Health, San Francisco, CA 94102, USA
    J Acquir Immune Defic Syndr 55:S128-31. 2010
    ..Future efficacy trial designs may incorporate novel, partially effective prevention strategies. Although greater in size and complexity, these trials may offer unique opportunities to explore synergies with vaccines under study...
  17. ncbi request reprint CROI 2014: new tools to track the epidemic and prevent HIV infections
    Susan P Buchbinder
    University of California San Francisco, San Francisco, CA, USA
    Top Antivir Med 22:579-93. 2014
    ..As adherence is a crucial determinant of PrEP efficacy, long-acting PrEP agents are promising approaches being tested. ..
  18. pmc Pre-exposure prophylaxis and the promise of combination prevention approaches
    Susan P Buchbinder
    HIV Research Section, San Francisco Department of Public Health, 25 Van Ness Avenue, Suite 500, San Francisco, CA 94102 6033, USA
    AIDS Behav 15:S72-9. 2011
    ..We also describe the rationale for combination prevention approaches that may combine PrEP with other prevention modalities as part of a larger prevention package...
  19. ncbi request reprint HIV epidemiology and breakthroughs in prevention 30 years into the AIDS epidemic
    Susan P Buchbinder
    University of California San Francisco, San Francisco, CA, USA
    Top Antivir Med 19:38-46. 2011
    ..Further progress is also being made in evaluating other prevention strategies and their rollout, including male condoms, male circumcision, and HIV testing and linkage to care...
  20. ncbi request reprint Partner-specific sexual behavioral differences between phase 3 HIV vaccine efficacy trial participants and controls: Project VISION
    William L H Whittington
    Department of Medicine, University of Washington, Seattle, WA 98104, USA
    J Acquir Immune Defic Syndr 43:234-8. 2006
    ..To assess and compare sexual behaviors using partner-specific data between HIV-negative men who have sex with men (MSM) recruited for an HIV vaccine efficacy trial and a control group...
  21. ncbi request reprint Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency virus acquisition in men who have sex with men
    Cristina Renzi
    Department of Medicine, University of Washington, Seattle, USA
    J Infect Dis 187:19-25. 2003
    ..HSV-2 increases the risk of HIV acquisition, independent of recognized herpes lesions and behaviors reflecting potential HIV exposure. HSV-2 suppression with antiviral therapy should be evaluated as an HIV prevention strategy among MSM...
  22. ncbi request reprint Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection
    Stephanie A Mulherin
    Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH DHHS, 6120 Executive Boulevard, Rockville, MD 20852, USA
    AIDS 17:377-87. 2003
    ..To examine temporal variation in the effects of CCR5-Delta32 and CCR2-64I chemokine receptor gene polymorphisms on HIV-1 disease progression...
  23. ncbi request reprint Beliefs about HIV reinfection (superinfection) and sexual behavior among a diverse sample of HIV-positive men who have sex with men
    Grant Nash Colfax
    J Acquir Immune Defic Syndr 36:990-2. 2004
  24. ncbi request reprint Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160
    Deborah Lee
    Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    J Infect Dis 190:903-7. 2004
    ..4, P =.1, and P =.7, respectively). Persons who acquire HIV-1 infection while enrolled in HIV-1 vaccine trials can be successfully followed after infection, to determine whether vaccines alter the course of HIV-1 infection...
  25. ncbi request reprint Alcohol use and high-risk sexual behavior among men who have sex with men: the effects of consumption level and partner type
    Peter A Vanable
    Department of Psychology and Center for Health and Behavior, Syracuse University, Syracuse, NY 13244 2340, USA
    Health Psychol 23:525-32. 2004
    ..Thus, the effects of alcohol vary according to the context in which it is used. Interventions to reduce substance-related risk should be tailored to the demands of maintaining sexual safety with nonprimary partners...
  26. ncbi request reprint Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study
    Sheldon R Morris
    Department of Community and Family Medicine, University of California San Francisco, USA
    Clin Infect Dis 43:1284-9. 2006
    ..We examined the prevalence, incidence, and sociodemographic and behavioral predictors of pharyngeal gonorrhea in a cohort of sexually active, human immunodeficiency virus-negative MSM...
  27. pmc Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial
    Nina D Russell
    Program in Infectious Diseases, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    J Acquir Immune Defic Syndr 44:203-12. 2007
    ..We conducted a phase 2 trial to determine if a canarypox vaccine candidate (vCP1452) administered with rgp120 subunit protein would "qualify" for a trial to define a correlate of efficacy...
  28. ncbi request reprint HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion
    Haynes W Sheppard
    Viral and Rickettsial Disease Laboratory, California Department of Health Services, Richmond, California 94804, USA
    J Acquir Immune Defic Syndr 29:307-13. 2002
    ..The pathogenic potential of these viruses may be different from late-stage X4 virus or early X4 virus acquired by individuals with other CCR5 genotypes...